Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology.
Iana H HaralambievaMichael J GibsonRichard B KennedyInna G OvsyannikovaNathaniel D WarnerDiane E GrillGregory A PolandPublished in: PloS one (2017)
Our study supports the use of this new technology, as well as the use of antibody profiles/patterns (rather than single antibody measures) as biomarkers of neutralizing antibody response and correlates of protective immunity in rubella virus serology.
Keyphrases